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Purpose: To report the case of a 52-year-old man with Purtscher's retinopathy as the presenting mani-
festation of immune thrombocytopenic purpura (ITP).
Observations: Treatment with corticosteroids led to the resolution of hematologic ﬁndings within 1
week, and normal visual acuity was achieved after 2 months with no additional treatment.
Conclusions and importance: This is the ﬁrst reported association between Purtscher's retinopathy and
ITP. Complement activation has been implicated in the pathogenesis of both ITP and Purtscher's reti-
nopathy, and we suggest that the patient's systemic process accounted for the retinal ﬁndings.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Purtscher's retinopathy is a rare retinal vasculopathy seen in
patients with a history of trauma or a variety of systemic diseases.
While the exact pathogenesis is unknown, the presumed mecha-
nism is embolic peripapillary terminal arteriolar occlusion. Sug-
gested emboli include complement-mediated leukoaggregates, air,
fat, ﬁbrin, or platelets.1 Immune thrombocytopenic purpura (ITP) is
an autoimmune disease characterized by a low platelet count and
the absence of any identiﬁable cause of thrombocytopenia. We
report the case of a man diagnosed with Purtscher's retinopathy
and ITP who had recovery of vision after systemic treatment of his
ITP.
2. Case report
A 52-year-old Caucasian man was referred with a two-day his-
tory of profound visual loss in both eyes. Four days prior, he had
developed a severe ﬂu-like illness, consisting of headache, body
ache, fever, and shortness of breath. Therewas no history of trauma.
Past medical history was signiﬁcant for a hospitalization at age 15
following a similar ﬂu-like illness with lower extremity “purple
spots.”
On our examination, BCVAwas 20/800 in each eye. Therewas no
relative afferent pupillary defect. Intraocular pressure and anterior
segment ﬁndings were normal in both eyes. Fundus examination
revealed multiple peripapillary polygonal areas of inner retinal
whitening in both eyes (Fig. 1). Optical coherence tomography
(OCT) demonstrated cystoid macular edema nasal to the fovea and
serous foveal detachment, left eye greater than right (Fig. 2).
Fluorescein angiography revealed areas of hyperﬂuorescence cor-
responding to some of the areas of retinal whitening seen clinically
(Fig. 3).
The patient was diagnosed with Purtscher's retinopathy. A
complete blood count obtained from his primary care physician
several days earlier revealed a low platelet count of 53,000/mL
(reference range: 150,000e400,000/mL). We initiated a workup,
and the patient was referred to the Massachusetts General Hospital
for additional systemic evaluation. The patient had no fever, rash,
history of recent trauma, or changes in medications. Chest x-ray,
thyroid function, renal function, amylase level, and lipase level
were normal. A complete blood count revealed a low platelet count
of 56,000 but was otherwise normal. Peripheral blood smear
showed no evidence of schistocytes. A diagnosis of ITP was made
and he was treated with oral prednisone 80 mg/day. The patient's
platelet count normalized to 239,000/mL and 336,000/mL after 4 and
5 days of treatment, respectively. Two months later, his vision
improved to 20/20 OD and 20/15 OS, although he continued to
complain of difﬁculty with driving and reading. Fundus examina-
tion revealed almost complete resolution of the white lesions
(Fig. 4), although OCT demonstrated areas of outer nuclear, outer
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plexiform, and inner nuclear layer thinning, left eye greater than
right (Fig. 5).
3. Discussion
We report the ﬁrst case of Purtscher's retinopathy in a patient
with ITP. Purtscher's retinopathy is a rare vaso-occlusive condition
that presents as profound visual loss associated with cotton wool
spots, intraretinal hemorrhages, and Purtscher ﬂecken, or polygonal
areas of inner retinal whitening between the retinal arterioles and
venules with a characteristic clear zone between the affected retina
and adjacent arterioles.2 While the pathogenesis remains unclear, a
commonly accepted mechanism is retinal embolization caused by
complement C5a-induced leukocyte aggregates.3,4 Purtscher's
retinopathy has been associated with complement-activating
conditions such as acute and chronic pancreatitis, trauma, and
collagen vascular diseases, as well as thrombotic thrombocytopenic
purpura and HELLP (hemolysis, elevated liver enzymes, low platelet
count) syndrome, which present with hematologic abnormalities
similar to ITP.1,5e8 Complement activation may be a common
causative mechanism of both Purtscher's retinopathy and ITP, and
Fig. 1. Baseline color fundus photographs of the right (A) and left (B) eyes demonstrate peripapillary discrete areas of inner retinal whitening (Purtscher ﬂecken).(For interpretation
of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. Baseline optical coherence tomography illustrates cystoid macular edema and serous foveal detachment in the right (A) and left (B) eyes.
Fig. 3. Baseline ﬂuorescein angiography (late phase) of the right (A) and left (B) eyes demonstrates areas of peripapillary hyperﬂuorescence.
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in this case, Purtscher's retinopathy was the presenting manifes-
tation of ITP.
In most patients, ITP is a self-limited, benign disorder. It is
mediated by autoantibodies that both accelerate platelet destruc-
tion and inhibit platelet production. Although an acute infection is
often the initial trigger of ITP, the exact pathophysiology of anti-
body production remains unknown.9 Complement activation is
implicated in the pathogenesis of ITP.10 The majority of patients
with ITP have been shown to have platelet autoantibodies that can
elevate complement activation above baseline,11,12 and comple-
ment may contribute to lysis of antibody-coated platelets.9 Most
patients with ITP experience only minor bleeding symptoms such
as mucosal bleeding, petechiae, and bruising. It is possible that our
patient's similar illness with “purple spots” at age 15 was childhood
ITP and that his most recent illness represented a recurrence.
Visual outcomes of Purtscher's retinopathy are variable andmay
depend on the underlying systemic condition.1We believe this case
lends additional support to the proposed role of complement
activation in the development of Purtcher's retinopathy, as this
pathologic process is an accepted mechanism in the development
of ITP. The improvement in our patient's vision and retinal ﬁndings
occurred in concert with the resolution of his ITP and lends validity
to this proposed pathophysiologic relationship. We hypothesize
that increased complement activation associated with ITP was the
cause of our patient's Purtscher's retinopathy.
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